Published in Obesity and Diabetes Week, May 29th, 2006
Incorporating data from a pooled, subset analysis of the company's two randomized, double-masked, placebo-controlled phase III clinical studies of Vitrase for the treatment of vitreous hemorrhage, the posters, entitled "A Simple Predictor of Vitrase Efficacy for BCVA Improvement in Diabetic Patients With Severe Vitreous Hemorrhage" and "A Simple Predictor of Vitrase Efficacy for Successful Laser Treatment in Diabetic Patients With...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.